18F –labeled estradiol derivative for targeting estrogen receptor-expressing breast cancer

A novel radiotracer 1-(2-(2-(2-[18F]fluoroethoxy)ethoxy)ethyl)-1H-1,2,3-triazole- estradiol ([18F]FETE) was successfully synthesized, characterized and evaluated in mice for estrogen receptor (ER)-positive breast cancer targeting with positron emission tomography (PET) imaging.

Source: Nuclear Medicine and Biology - February 2, 2018 Category: Nuclear Medicine Authors: Duo Xu, Rongqiang Zhuang, Linyi You, Zhide Guo, Xiangyu Wang, Chenyu Peng, Deliang Zhang, Pu Zhang, Hua Wu, Weimin Pan, Xianzhong Zhang Source Type: research